Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 5Breast 3Tumor-Agnostic 2Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2Breast Cancer Screening 1

Interventions

Trastuzumab 260Paclitaxel 216Cyclophosphamide 173Docetaxel 146Letrozole 126Fulvestrant 121Capecitabine 121Doxorubicin 111Carboplatin 98Bevacizumab 90exemestane 88Anastrozole 85Tamoxifen 77Lapatinib 77pembrolizumab 68Albumin-Bound Paclitaxel 67pertuzumab 62palbociclib 60Taxes 59Gemcitabine 57eribulin 48130-nm albumin-bound paclitaxel 47Radiotherapy 46Everolimus 44Ado-Trastuzumab Emtansine 43Vinorelbine 39ixabepilone 32Epirubicin 30Cisplatin 30pegfilgrastim 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Decision Support Techniques × Breast × Clear all
NCT05376241 2026-03-27

Promoting Informed Choice for Breast Cancer Screening

University of Colorado, Denver

Phase 2 Completed
637 enrolled 10 charts
Breast

Breast Neoplasms

NCT04601272 2023-03-30

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

Massachusetts General Hospital

Completed
240 enrolled 14 charts
BreastGastrointestinalGenitourinary

Breast Cancer Screening

NCT03097653 2021-03-24

Decision-aid on Breast Cancer Screening

Mario Negri Institute for Pharmacological Research

Phase NA Completed
1,001 enrolled 17 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡